Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec
  • MACS® Cell Analysis
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Cell separation reagents Cell separation reagents
  for human cells
  Stem and progenitor cells
  T cells
 
 
 
 
 
  NK cells
  B Cells
  Monocytes
  Dendritic cells
  Antigen-presenting cells
  Granulocytes and myeloid cells
  Leukocytes
  Erythroid cells
  Megakaryocytes and platelets
  Endothelial cells
  Epithelial cells
  Fibroblasts
  Neural cells
  Cytokine-producing cells
  Tumor cells
  Fc receptor blocking
  for non-human primate cells
  for mouse cells
  for rat cells
  for indirect magnetic labeling
  for apoptotic and dead cells
  for isolation of mitochondria
Manual cell separation Manual cell separation
Automated cell separation Automated cell separation
MACS® Technology MACS® Technology
Miltenyi Biotec
MACS eNews
Subscribe to our
MACS eNews
for regular product information via e-mail.
Miltenyi Biotec
CD4<sup>+</sup>CD25<sup>+</sup> Regulatory T Cell Isolation Kit

CD4+CD25+ Regulatory T Cell Isolation Kit

  • Excellent tool to isolate both Treg cells and CD4+ T cells for functional analysis
  • Cells can be directly used for downstream assays
  • Outstanding purity and unmatched recovery
Description
The CD4+CD25+ Regulatory T Cell Isolation Kit was developed for the isolation of CD4+CD25+ cells from human PBMCs. The isolation is performed in a two-step procedure.
Details
Background information
Regulatory CD4+CD25+ T cells are suppressor cells that neutralize other immune cells by various mechanisms. Their characteristic marker is the transcription factor FoxP3. Regulatory CD4+CD25+ T cells seem to suppress harmful immunological reactions to self or foreign antigens.

Detailed separation procedure

The isolation is performed in a two-step procedure. First, non-CD4+ T cells are indirectly magnetically labeled with a cocktail of biotin-conjugated antibodies against CD8, CD14, CD16, CD19, CD36, CD56, CD123, TCRγ/δ and CD235a (glycophrin A) and Anti-Biotin MicroBeads. The labeled cells are subsequently depleted over a MACS® Column. In the second step, the flow-through fraction of pre-enriched CD4+CD45RA+ T cells is labeled with CD25 MicroBeads for subsequent positive selection of CD4+CD25+ regulatory T cells.

Downstream applications
The CD4+CD25+ Regulatory T Cell Isolation Kit has been used to investigate the role of CD4+CD25+ regulatory T cells in autoimmune diseases1,2, antitumor immunity3–6, allergy7, and in infectious diseases8. For further characterization, CD4+CD25+ regulatory T cells were isolated from patients suffering from rheumatoid arthritis1 or multiple sclerosis2, from acute T cell lymphoma patients4, from tumor biopsy specimens of non-Hodgkin lymphoma patients5, after dendritic cell vaccination9 as well as from patients with atopic dermatitis7.
Columns
For depletion: LD or autoMACS Columns. For positive selection: MS or autoMACS Columns.
 
Figure 1
CD4+CD25+ regulatory T cells were isolated from human PBMCs. The cells were fluorescently stained as indicated and analyzed by flow cytometry using the MACSQuant® Analyzer. Gating was performed according to CD4 expression except for the CD25-APC vs. CD4 (VIT4)-VioBlue dot plot.
Before separation
A
B
Isolated CD4+CD25+ regulatory T cells
A
B
C
Pre-enriched CD4+ T cells
A
Miltenyi Biotec
Search this website
Advanced search
Toolbox
Customer login
Contact
Newsletter
Help
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
CD4+CD25+ Regulatory T Cell Isolation Kit, human
- for 109 total cells
Download datasheet
130-091-301
Qty.:
 

Related products
CD4 antibodies
MACS® Cell Analysis Reagents
Anti-FoxP3 antibodies
CD4+CD25+CD127dim/– Regulatory T Cell Isolation Kit II
Treg Suppression Inspector, human
References
1. Ehrenstein et al. (2004) J. Exp. Med. 200: 277-285.
2. Hong et al. (2006) Proc. Natl. Acad. Sci. USA 103: 5024-5029.
3. Nishikawa et al. (2006) J. Immunol. 176: 6340-6346.
4. Karube et al. (2004) Br. J. Haematol. 126: 81-84.
5. Yang et al. (2006) Blood 107: 3639-3646.
6. Mougiakakos et al. (2009) Blood 113: 3542-3545.
7. Ou et al. (2004) J. Allergy Clin. Immunol. 113: 756-763.
8. Xu et al. (2006) J. Immunol. 177: 739-747.
9. Schwaab et al. (2009) Clin. Cancer Res. 15: 4986-4992.
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website